# Biomerica Inc. (BMRA)

Source: https://www.quantisnow.com/company/BMRA
Generated: 2026-11-18T21:55:19.568Z

- Ticker: BMRA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SEC CIK: 0000073290
- Website: biomerica.com

## About

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

## Latest BMRA news and filings

- 2026-10-16 21:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-biomerica-inc-6749459)
- 2026-10-16 12:19 UTC [Biomerica Reports First Quarter Fiscal 2027 Financial Results](https://www.quantisnow.com/insight/biomerica-reports-first-quarter-fiscal-2027-financial-results-6748722)
- 2026-10-15 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biomerica-inc-6748322)
- 2026-10-15 21:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-biomerica-inc-6748313)
- 2026-10-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biomerica-inc-6740874)
- 2026-10-08 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biomerica-inc-6740872)
- 2026-09-28 21:00 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Biomerica Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-biomerica-inc-6727995)
- 2026-09-25 18:55 UTC [SEC Form S-3] [SEC Form S-3 filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-biomerica-inc-6726320)
- 2026-09-24 21:00 UTC [SEC Form S-3] [SEC Form S-3 filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-biomerica-inc-6725698)
- 2026-09-08 20:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Qu Xiaoxuan](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-qu-xiaoxuan-6708485)
- 2026-09-01 12:19 UTC [Biomerica Reports Fiscal 2026 Year-End Financial Results](https://www.quantisnow.com/insight/biomerica-reports-fiscal-2026-year-end-financial-results-6700666)
- 2026-08-31 21:00 UTC [SEC Form 10-K] [SEC Form 10-K filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-biomerica-inc-6700029)
- 2026-08-27 21:27 UTC [Insider Buy] [Director Gary M. Huff bought $50,000 worth of shares (31,250 units at $1.60), increasing direct ownership by 156% to 51,250 units (SEC Form 4)](https://www.quantisnow.com/insight/director-gary-m-huff-bought-50000-worth-of-shares-31250-6697566)
- 2026-08-27 21:26 UTC [Insider Buy] [Director Moatazedi David bought $16,000 worth of shares (10,000 units at $1.60), increasing direct ownership by 33% to 40,625 units (SEC Form 4)](https://www.quantisnow.com/insight/director-moatazedi-david-bought-16000-worth-of-shares-10000-units-6697548)
- 2026-08-27 21:26 UTC [Insider Buy] [Director Chin Eric bought $10,000 worth of shares (6,250 units at $1.60), increasing direct ownership by 19% to 38,750 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chin-eric-bought-10000-worth-of-shares-6250-units-6697542)
- 2026-08-27 21:23 UTC [Insider Buy] [Chief Executive Officer Irani Zackary S. bought $50,000 worth of shares (31,250 units at $1.60), increasing direct ownership by 15% to 242,570 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-irani-zackary-s-bought-50000-worth-of-6697535)
- 2026-08-27 21:24 UTC [Insider Buy] [Executive Vice Chairman Barbieri Allen bought $32,000 worth of shares (20,000 units at $1.60), increasing direct ownership by 37% to 73,542 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vice-chairman-barbieri-allen-bought-32000-worth-of-shares-6697532)
- 2026-08-27 12:19 UTC [Biomerica Announces $2.23 Million Financing](https://www.quantisnow.com/insight/biomerica-announces-223-million-financing-6696507)
- 2026-08-26 20:54 UTC [SEC Form 8-K] [Biomerica Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biomerica-inc-filed-sec-form-8-k-entry-into-a-material-6695877)
- 2026-06-04 20:45 UTC [SEC Form 8-K] [Biomerica Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biomerica-inc-filed-sec-form-8-k-entry-into-a-material-6589775)
- 2026-05-28 12:19 UTC [Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development](https://www.quantisnow.com/insight/biomerica-lands-a-175-million-cdmo-master-services-agreement-for-6576268)
- 2026-05-19 13:00 UTC [Leadership Update] [ConsumerDirect Expands Executive Team with Appointment of Gary Lu, CPA as Chief Financial Officer](https://www.quantisnow.com/insight/consumerdirect-expands-executive-team-with-appointment-of-gary-lu-cpa-6561952)
- 2026-05-05 11:04 UTC [Analyst Coverage Initiated] [Citizens initiated coverage on Biomerica with a new price target](https://www.quantisnow.com/insight/citizens-initiated-coverage-on-biomerica-with-a-new-price-target-6530692)
- 2026-04-29 12:19 UTC [Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026](https://www.quantisnow.com/insight/biomericas-infoods-ibs-data-accepted-for-presentation-at-digestive-disease-6520298)
- 2026-04-16 12:19 UTC [Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway](https://www.quantisnow.com/insight/biomerica-announces-medicare-administrative-contractor-confirmation-of-individual-claim-review-6502412)
- 2026-04-14 12:19 UTC [Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs](https://www.quantisnow.com/insight/biomerica-launches-infoods-ibs-in-canada-through-partnerships-with-phoenix-6498844)
- 2026-04-13 22:57 UTC [Biomerica Reports Third Quarter Fiscal 2026 Financial Results](https://www.quantisnow.com/insight/biomerica-reports-third-quarter-fiscal-2026-financial-results-6498353)
- 2026-04-13 21:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biomerica-inc-6498208)
- 2026-03-18 12:19 UTC [Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe](https://www.quantisnow.com/insight/biomerica-receives-first-commercial-order-for-its-h-pylori-test-6455313)
- 2026-03-05 13:19 UTC [Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain](https://www.quantisnow.com/insight/biomerica-receives-mhra-registration-for-hpdetect-allowing-commercial-sales-in-6431593)
- 2026-02-27 22:15 UTC [SEC Form S-8] [SEC Form S-8 filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-biomerica-inc-6419901)
- 2026-02-26 13:19 UTC [Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy](https://www.quantisnow.com/insight/biomerica-reports-real-world-data-nearly-60-of-ibs-patients-achieved-6415096)
- 2026-02-18 13:19 UTC [Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution](https://www.quantisnow.com/insight/vietnam-approves-biomericas-ez-detect-for-nationwide-distribution-6398379)
- 2026-01-28 22:40 UTC [SEC Form 4] [Director Chin Eric was granted 22,500 shares, increasing direct ownership by 225% to 32,500 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chin-eric-was-granted-22500-shares-increasing-direct-ownership-6364580)
- 2026-01-14 22:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Biomerica Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-biomerica-inc-6349758)
- 2025-12-31 22:10 UTC [SEC Form 4] [Chief Financial Officer Lu Gary was granted 40,000 shares, increasing direct ownership by 206% to 59,375 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-lu-gary-was-granted-40000-shares-increasing-6331097)
- 2025-12-31 22:10 UTC [SEC Form 4] [Executive Vice-Chairman Barbieri Allen was granted 30,000 shares, increasing direct ownership by 127% to 53,543 units (SEC Form 4)](https://www.quantisnow.com/insight/executive-vice-chairman-barbieri-allen-was-granted-30000-shares-increasing-direct-6331096)
- 2025-12-31 22:10 UTC [SEC Form 4] [Director Gary M. Huff was granted 20,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-gary-m-huff-was-granted-20000-shares-sec-form-6331094)
- 2025-12-31 22:10 UTC [SEC Form 4] [Chief Executive Officer Irani Zackary S. was granted 52,500 shares, increasing direct ownership by 33% to 211,320 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-irani-zackary-s-was-granted-52500-shares-6331093)
- 2025-12-31 22:10 UTC [SEC Form 4] [Director Moatazedi David was granted 20,000 shares, increasing direct ownership by 188% to 30,625 units (SEC Form 4)](https://www.quantisnow.com/insight/director-moatazedi-david-was-granted-20000-shares-increasing-direct-ownership-6331092)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BMRA
- Earnings history: https://www.quantisnow.com/earnings/BMRA
- Dividend history: https://www.quantisnow.com/dividends/BMRA
- Insider transactions: https://www.quantisnow.com/insiders/BMRA
- Options chain: https://www.quantisnow.com/options/BMRA
- SEC 8-K filings only: https://www.quantisnow.com/company/BMRA/8-k
- RSS and alerts for BMRA: https://www.quantisnow.com/docs/rss-feeds.md
